The muscular dystrophies, or MD, are a group of more than 30 genetic neuromuscular disorders, in which defects of muscle cause muscle weakness and difficulties in body movement and control.
What Is Muscular Dystrophy?
The muscular dystrophies, or MD, are a group of more than 30 genetic (passed down by parents) neuromuscular disorders, in which defects of muscle (not nerves) cause muscle weakness and difficulties in body movement and control. Each type of muscular dystrophy is passed on by a different gene, and they all have different courses. However, all of the disorders are always progressive (worsen over time), and always involve destruction and death of muscle fibers at some stage of the disease. MD can begin in infancy, childhood, or adulthood. However, those which start in early childhood are most severe.
Major Forms of Muscular Dystrophy
There are seven major types of muscular dystrophy that affect children and young adults:
Duchenne Muscular Dystrophy: Ryan's Story
Duchenne muscular dystrophy is a life-threatening and muscle-deteriorating disease. But thanks to pioneering new treatments, 12 year-old Ryan is still walking.
What Are the Symptoms of Muscular Dystrophy?
Symptoms are different, depending on the type of muscular dystrophy. Every muscle in the body may be affected in some types. While, only certain muscles may be affected in others.
Symptoms may include:
- Muscle weakness that slowly gets worse
- Delayed motor skill development
- Difficulty controlling or using muscle groups
- Frequent falls or poor balance
- Decrease in muscle size
- Difficulty walking or delay in starting to walk
How Is Muscular Dystrophy Diagnosed?
- DNA blood test
- Muscle biopsy
- Electromyelogram (EMG)
- Clinical exam findings
How Is Muscular Dystrophy Treated?
Muscular dystrophy cannot be prevented. There is no specific treatment or cure for the disease. Care of those with muscular dystrophy is mainly focused on preventing and treating its complications, and improving the quality of life of affected children. Multiple pediatric specialists, including orthopedic surgeons, physical therapists, cardiologists, pulmonologists, nutritionists, and physical medicine specialists, make up the team that provides the necessary care to achieve this.
Each child is thoroughly evaluated and a treatment plan is determined based on their individual diagnosis and prognosis. Nationwide Children’s program has enabled our pediatric patients to live more comfortably, be more productive, and in many cases, live longer lives.
You Might Also Be Interested In
Encouraging First Report of Systemic Delivery of Micro-dystrophin Gene Therapy in Children With DMD
Researchers have published results from the first four patients treated in the first clinical trial of systemic delivery of micro-dystrophin gene therapy in children with Duchenne muscular dystrophy. Initial findings suggest that the therapy can provide functional improvement that is greater than that observed under the standard of care.
A Natural History of Duchenne Muscular Dystrophy in Boys 3 to 6 Years Old
A prospective, multicenter study following 153 boys younger than 6 years old documents disease progression of Duchenne muscular dystrophy.
Cheaper, Generic Drug Just as Effective in Preserving Heart Function in Duchenne Muscular Dystrophy
A new clinical trial found a cheaper generic drug is effective in protecting the heart in boys with Duchenne muscular dystrophy.